Skip to content

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03013842
Enrollment
6
Registered
2017-01-09
Start date
2016-12-12
Completion date
2017-08-02
Last updated
2018-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Abdominal

Keywords

pregnancy, fetal monitoring, fetal oximetry, fetal heart rate, pulse oximetry, near infrared spectroscopy

Brief summary

Three non-invasive, trans-abdominal fetal oximetry probes will be tested on pregnant human subjects, in order to obtain fetal heart rate. We want to determine if this device can accurately measure a baby's oxygen level when placed on your abdomen. Current technology to measure a baby's oxygen levels requires a probe to be inserted into the vagina.

Detailed description

The study subject will have a brief trans-abdominal ultrasound examination. 3 trans-abdominal fetal oximetry probes will be tested for 5 minutes per probe. No probes will be placed into the vagina. It is anticipated that 6 months will be required to recruit, consent and study 25 participants.

Interventions

DEVICERaydiant Oximetry Sensor System

Administration of Fetal Oximetry Probe on 36 weeks or greater pregnant women

Sponsors

CITRIS
CollaboratorUNKNOWN
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Greater than 36 weeks pregnant * Singleton fetus

Exclusion criteria

* Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Fetal Photoplethysmogram6 monthsThe primary outcome measure will be if a fetal photoplethysmogram is obtained in the time domain that correlates to the fetal heart rate.

Secondary

MeasureTime frameDescription
Fetal Heart Rate6 monthsThe secondary endpoint will be if fetal heart rate can be obtained in the frequency domain that correlates to a fetal heart rate obtained by Doppler.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026